去年，阿斯利康表现最佳的业务板块Farxiga实现营收8.40B美元。United States的营收贡献最高，去年达到23.97B美元。最近一个季度，截至2026-06-30，阿斯利康表现最佳的业务板块Calquenc实现营收61.02B美元。United States的营收贡献最高，达到6.68B美元。

业务

营业收入

占比

年报

年报

单季报

Farxiga

Tagrisso

Imfinzi

Ultomiris

Calquenc

Lynparza

Symbicort

Fasenra

Soliris

Strensiq

Crestor

Breztri

Zoladex

Enhertu

Brilinta

Nexium

Truqap

Lokelma

Saphnelo

Koselugo

Seloken/Toprol-XL

BioPharmaceuticals: CVRM Others

Pulmicort

Tezspire

Oncology Others

Imjudo

Synagis

Beyfortus

BioPharmaceuticals: Respiratory & Immunology Others

Roxadustat

FluMist

rare disease - Other

Wainua

Airsupra

Other medicines others

Datroway

Vaccines & Immune Therapies Others

Andexxa

Kanuma

Orpathys

COVID-19 mAbs

Vaxzevria

Faslodex

Onglyza

Bydureon

Bevespi

Daliresp/Daxas Bevespi

Evusheld

Iressa

Arimidex

Casodex

Covid

Losec/Prilosec

Atacand

Seroquel XR/IR

Other diabetes

Byetta

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Farxiga

8.40B(15.12%)

7.66B(15.03%)

5.96B(13.62%)

4.38B(10.19%)

3.00B(8.21%)

1.96B(7.57%)

Tagrisso

7.25B(13.05%)

6.58B(12.92%)

5.80B(13.24%)

5.44B(12.66%)

5.01B(13.72%)

4.33B(16.72%)

Imfinzi

6.06B(10.91%)

4.72B(9.26%)

4.24B(9.68%)

2.78B(6.47%)

2.41B(6.60%)

2.04B(7.89%)

Ultomiris

4.72B(8.49%)

3.92B(7.70%)

2.96B(6.77%)

1.97B(4.57%)

688.00M(1.88%)

--(--)

Calquenc

3.52B(6.33%)

3.13B(6.14%)

2.51B(5.74%)

2.06B(4.78%)

1.24B(3.39%)

522.00M(2.02%)

Lynparza

3.28B(5.90%)

3.07B(6.03%)

2.81B(6.42%)

2.64B(6.14%)

2.35B(6.43%)

1.78B(6.86%)

Symbicort

2.88B(5.19%)

2.88B(5.65%)

2.36B(5.39%)

2.54B(5.90%)

2.73B(7.47%)

2.72B(10.51%)

Fasenra

1.98B(3.56%)

1.69B(3.32%)

1.55B(3.55%)

1.40B(3.25%)

1.26B(3.44%)

949.00M(3.67%)

Soliris

1.84B(3.31%)

2.59B(5.08%)

3.15B(7.18%)

3.76B(8.75%)

1.87B(5.13%)

--(--)

Strensiq

1.68B(3.02%)

1.42B(2.78%)

1.15B(2.63%)

958.00M(2.23%)

378.00M(1.03%)

--(--)

Crestor

1.22B(2.19%)

1.15B(2.26%)

1.11B(2.53%)

1.05B(2.44%)

1.10B(3.00%)

1.18B(4.56%)

Breztri

1.20B(2.16%)

978.00M(1.92%)

677.00M(1.55%)

398.00M(0.93%)

203.00M(0.56%)

28.00M(0.11%)

Zoladex

1.11B(1.99%)

1.06B(2.08%)

952.00M(2.17%)

927.00M(2.16%)

948.00M(2.59%)

888.00M(3.43%)

Enhertu

977.00M(1.76%)

545.00M(1.07%)

261.00M(0.60%)

79.00M(0.18%)

17.00M(0.05%)

--(--)

Brilinta

823.00M(1.48%)

1.33B(2.62%)

1.32B(3.02%)

1.36B(3.16%)

1.47B(4.03%)

1.59B(6.15%)

Nexium

816.00M(1.47%)

867.00M(1.70%)

945.00M(2.16%)

1.28B(2.99%)

1.33B(3.63%)

1.49B(5.76%)

Truqap

728.00M(1.31%)

430.00M(0.84%)

6.00M(0.01%)

--(--)

Lokelma

698.00M(1.26%)

542.00M(1.06%)

412.00M(0.94%)

289.00M(0.67%)

175.00M(0.48%)

76.00M(0.29%)

Saphnelo

686.00M(1.23%)

467.00M(0.92%)

278.00M(0.63%)

116.00M(0.27%)

8.00M(0.02%)

--(--)

Koselugo

662.00M(1.19%)

531.00M(1.04%)

331.00M(0.76%)

208.00M(0.48%)

108.00M(0.30%)

38.00M(0.15%)

Seloken/Toprol-XL

607.00M(1.09%)

605.00M(1.19%)

640.00M(1.46%)

862.00M(2.00%)

951.00M(2.60%)

821.00M(3.17%)

BioPharmaceuticals: CVRM Others

534.00M(0.96%)

524.00M(1.03%)

296.00M(0.68%)

366.00M(0.85%)

196.00M(0.54%)

191.00M(0.74%)

Pulmicort

518.00M(0.93%)

682.00M(1.34%)

713.00M(1.63%)

645.00M(1.50%)

962.00M(2.63%)

996.00M(3.85%)

Tezspire

458.00M(0.82%)

248.00M(0.49%)

85.00M(0.19%)

4.00M(0.01%)

--(--)

Oncology Others

425.00M(0.76%)

419.00M(0.82%)

224.00M(0.51%)

44.00M(0.10%)

50.00M(0.14%)

51.00M(0.20%)

Imjudo

346.00M(0.62%)

281.00M(0.55%)

--(--)

Synagis

292.00M(0.53%)

447.00M(0.88%)

546.00M(1.25%)

578.00M(1.34%)

410.00M(1.12%)

372.00M(1.44%)

Beyfortus

281.00M(0.51%)

316.00M(0.62%)

106.00M(0.24%)

--(--)

BioPharmaceuticals: Respiratory & Immunology Others

274.00M(0.49%)

400.00M(0.79%)

324.00M(0.74%)

421.00M(0.98%)

594.00M(1.63%)

398.00M(1.54%)

Roxadustat

274.00M(0.49%)

331.00M(0.65%)

271.00M(0.62%)

197.00M(0.46%)

174.00M(0.48%)

--(--)

FluMist

272.00M(0.49%)

258.00M(0.51%)

216.00M(0.49%)

175.00M(0.41%)

253.00M(0.69%)

295.00M(1.14%)

rare disease - Other

231.00M(0.42%)

--(--)

Wainua

212.00M(0.38%)

85.00M(0.17%)

--(--)

Airsupra

166.00M(0.30%)

66.00M(0.13%)

--(--)

Other medicines others

156.00M(0.28%)

206.00M(0.40%)

231.00M(0.53%)

340.00M(0.79%)

106.00M(0.29%)

128.00M(0.49%)

Datroway

2.00M(--)

--(--)

Vaccines & Immune Therapies Others

1.00M(--)

4.00M(0.01%)

--(--)

Andexxa

--(--)

219.00M(0.43%)

182.00M(0.42%)

150.00M(0.35%)

68.00M(0.19%)

--(--)

Kanuma

--(--)

209.00M(0.41%)

171.00M(0.39%)

160.00M(0.37%)

62.00M(0.17%)

--(--)

Orpathys

--(--)

44.00M(0.09%)

44.00M(0.10%)

33.00M(0.08%)

16.00M(0.04%)

--(--)

COVID-19 mAbs

--(--)

31.00M(0.06%)

132.00M(0.30%)

--(--)

Vaxzevria

--(--)

4.00M(0.01%)

12.00M(0.03%)

1.80B(4.18%)

--(--)

Faslodex

--(--)

297.00M(0.68%)

334.00M(0.78%)

431.00M(1.18%)

580.00M(2.24%)

Onglyza

--(--)

227.00M(0.52%)

257.00M(0.60%)

360.00M(0.99%)

470.00M(1.82%)

Bydureon

--(--)

163.00M(0.37%)

280.00M(0.65%)

385.00M(1.05%)

448.00M(1.73%)

Bevespi

--(--)

58.00M(0.13%)

54.00M(0.15%)

48.00M(0.19%)

Daliresp/Daxas Bevespi

--(--)

54.00M(0.12%)

189.00M(0.44%)

227.00M(0.62%)

217.00M(0.84%)

Evusheld

--(--)

2.19B(5.08%)

--(--)

Iressa

--(--)

114.00M(0.27%)

183.00M(0.50%)

268.00M(1.04%)

Arimidex

--(--)

99.00M(0.23%)

139.00M(0.38%)

185.00M(0.71%)

Casodex

--(--)

78.00M(0.18%)

143.00M(0.39%)

172.00M(0.66%)

Covid

--(--)

4.00B(10.95%)

--(--)

Losec/Prilosec

--(--)

180.00M(0.49%)

183.00M(0.71%)

Atacand

--(--)

97.00M(0.27%)

243.00M(0.94%)

Seroquel XR/IR

--(--)

92.00M(0.25%)

117.00M(0.45%)

Other diabetes

--(--)

59.00M(0.16%)

47.00M(0.18%)

Byetta

--(--)

55.00M(0.15%)

68.00M(0.26%)

地区

营业收入

占比

年报

年报

单季报

United States

China

United Kingdom

Other European Countries

Japan

Germany

Other Asia, Africa & Australasia

Central America/Other South American Countries

Sweden

France

Spain

Italy

Canada

Australia

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

23.97B(40.81%)

21.81B(40.33%)

18.12B(39.56%)

17.28B(38.96%)

12.05B(32.20%)

8.96B(33.64%)

8.05B(33.00%)

China

6.64B(11.30%)

6.42B(11.87%)

5.87B(12.82%)

5.74B(12.95%)

6.00B(16.04%)

5.34B(20.08%)

4.87B(19.96%)

United Kingdom

4.36B(7.42%)

4.74B(8.77%)

3.37B(7.35%)

3.12B(7.03%)

3.25B(8.67%)

1.74B(6.54%)

1.82B(7.47%)

Other European Countries

4.32B(7.35%)

3.66B(6.77%)

3.11B(6.79%)

2.71B(6.10%)

1.95B(5.21%)

1.39B(5.23%)

1.29B(5.29%)

Japan

3.56B(6.05%)

3.45B(6.38%)

3.64B(7.95%)

3.99B(8.99%)

3.40B(9.07%)

2.57B(9.64%)

2.52B(10.34%)

Germany

2.89B(4.92%)

2.52B(4.67%)

2.10B(4.58%)

1.90B(4.29%)

1.49B(3.97%)

937.00M(3.52%)

704.00M(2.89%)

Other Asia, Africa & Australasia

2.72B(4.63%)

2.33B(4.31%)

2.04B(4.46%)

2.41B(5.42%)

2.38B(6.36%)

1.53B(5.76%)

1.42B(5.82%)

Central America/Other South American Countries

2.63B(4.48%)

2.25B(4.15%)

1.68B(3.67%)

1.18B(2.65%)

1.20B(3.22%)

761.00M(2.86%)

814.00M(3.34%)

Sweden

2.62B(4.47%)

2.29B(4.24%)

1.70B(3.72%)

1.72B(3.88%)

2.32B(6.21%)

1.03B(3.85%)

834.00M(3.42%)

France

1.41B(2.40%)

1.28B(2.37%)

1.15B(2.51%)

1.11B(2.50%)

915.00M(2.45%)

653.00M(2.45%)

578.00M(2.37%)

Spain

1.14B(1.93%)

994.00M(1.84%)

847.00M(1.85%)

738.00M(1.66%)

578.00M(1.54%)

398.00M(1.50%)

359.00M(1.47%)

Italy

1.08B(1.84%)

949.00M(1.76%)

813.00M(1.77%)

735.00M(1.66%)

577.00M(1.54%)

431.00M(1.62%)

396.00M(1.62%)

Canada

954.00M(1.62%)

937.00M(1.73%)

967.00M(2.11%)

1.17B(2.63%)

772.00M(2.06%)

596.00M(2.24%)

466.00M(1.91%)

Australia

454.00M(0.77%)

439.00M(0.81%)

390.00M(0.85%)

571.00M(1.29%)

547.00M(1.46%)

282.00M(1.06%)

266.00M(1.09%)